Viyash Scientific · NSE: VIYASH · BSE: 512529
Q3 FY25 results · Oct–Dec 2024
Viyash Scientific reported revenue from operations of ₹390.81 crore (up 18.7% from Q3 FY24) and net profit of ₹6.48 crore (down 39.3% from Q3 FY24) for Q3 FY25 (Oct–Dec 2024), on a consolidated basis.
| Item | Q3 FY25 | Q3 FY24 | YoY | Q2 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 390.81 | 329.36 | +18.7% | 368.65 | +6.0% |
| Other income | 5.84 | 4.52 | +29.3% | 4.51 | +29.5% |
| Total income | 396.65 | 333.88 | +18.8% | 373.16 | +6.3% |
| Profit before tax | 8.10 | 1.49 | +443.3% | 7.90 | +2.5% |
| Net profit for the period | 6.48 | 10.68 | −39.3% | 6.34 | +2.2% |
| Attributable to shareholders of the company | 3.44 | 8.27 | −58.4% | — | — |
| EPS, basic (₹) | 0.14 | 0.33 | −58.6% | 0.10 | +38.0% |
| Net margin (%) | 1.7 | 3.2 | 1.7 |
| Item | Q3 FY25 | Q3 FY24 | YoY | Q2 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 36.27 | 42.20 | −14.1% | 41.99 | −13.6% |
| Other income | 11.88 | 13.44 | −11.6% | 15.95 | −25.5% |
| Total income | 48.15 | 55.65 | −13.5% | 57.94 | −16.9% |
| Profit before tax | 3.68 | 6.09 | −39.6% | 6.41 | −42.6% |
| Net profit for the period | 2.81 | 4.58 | −38.6% | 4.26 | −34.0% |
| EPS, basic (₹) | 0.11 | 0.18 | −40.2% | 0.17 | −35.3% |
| Net margin (%) | 7.7 | 10.9 | 10.1 |
Consolidated
- Filed with BSE
- 11 Feb 2025, 16:04 IST
- Board meeting
- 11 Feb 2025
- Period
- 01 Oct 2024 to 31 Dec 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 11 Feb 2025, 16:04 IST
- Board meeting
- 11 Feb 2025
- Period
- 01 Oct 2024 to 31 Dec 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE